Over the past 12 months, 0 insiders at Axonics, Inc. filed 0 open-market SEC Form 4 transactions on AXNX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 24 | Kari Leigh KeeseChief Financial Officer | SELL | 2.6K | $69.41 | $180K |
| Jan 31, 24 | Raymond W CohenChief Executive Officer | SELL | 35.2K | $67.74 | $2.4M |
| Jan 31, 24 | Alfred J Ford JrChief Commercial Officer | SELL | 16.6K | $67.74 | $1.1M |
| Jan 31, 24 | Kari Leigh KeeseChief Financial Officer | SELL | 3.5K | $67.74 | $236K |
| Jan 31, 24 | Karen NoblettChief Medical Officer | SELL | 11.3K | $67.74 | $765K |
| Jan 31, 24 | John WoockEVP, Chief Mktg/Strtgy Officer | SELL | 15.9K | $67.74 | $1.1M |
| Jan 8, 24 | Karen NoblettChief Medical Officer | SELL | 16.0K | $69.00 | $1.1M |
| Dec 28, 23 | Karen NoblettChief Medical Officer | SELL | 7.1K | $63.28 | $446K |
| Dec 26, 23 | Karen NoblettChief Medical Officer | SELL | 949 | $63.00 | $60K |
| Sep 29, 23 | Danny L. DearenPresident & CFO | SELL | 7.7K | $56.87 | $436K |
| Aug 15, 23 | Alfred J Ford JrChief Commercial Officer | SELL | 14.8K | $62.34 | $921K |
| Jul 28, 23 | Alfred J Ford JrChief Commercial Officer | SELL | 1.5K | $62.01 | $93K |
| May 26, 23 | Danny L. DearenPresident & CFO | SELL | 7.7K | $50.14 | $381K |
| Apr 21, 23 | Danny L. DearenPresident & CFO | SELL | 10.4K | $60.50 | $621K |
| Apr 20, 23 | Danny L. DearenPresident & CFO | SELL | 2.0K | $60.01 | $120K |
| Mar 31, 23 | Danny L. DearenPresident & CFO | SELL | 7.8K | $55.68 | $434K |
| Feb 21, 23 | Rinda SamaChief Operating Officer | SELL | 16.2K | $56.69 | $912K |
| Feb 1, 23 | Raymond W CohenChief Executive Officer | SELL | 6.9K | $61.02 | $423K |
| Feb 1, 23 | Danny L. DearenPresident & CFO | SELL | 2.8K | $61.02 | $169K |
| Feb 1, 23 | Alfred J Ford JrChief Commercial Officer | SELL | 3.2K | $61.02 | $193K |
| Feb 1, 23 | Karen NoblettChief Medical Officer | SELL | 795 | $61.02 | $49K |
| Feb 1, 23 | Rinda SamaChief Operating Officer | SELL | 4.3K | $61.02 | $264K |
| Feb 1, 23 | John WoockEVP, Chief Mktg/Strtgy Officer | SELL | 3.4K | $61.02 | $207K |
| Jan 31, 23 | Raymond W CohenChief Executive Officer | SELL | 13.9K | $61.17 | $849K |
| Jan 31, 23 | Danny L. DearenPresident & CFO | SELL | 7.8K | $61.17 | $477K |
| Jan 31, 23 | Alfred J Ford JrChief Commercial Officer | SELL | 4.2K | $61.17 | $259K |
| Jan 31, 23 | Karen NoblettChief Medical Officer | SELL | 2.2K | $61.17 | $133K |
| Jan 31, 23 | Rinda SamaChief Operating Officer | SELL | 7.8K | $61.17 | $477K |
| Jan 31, 23 | John WoockEVP, Chief Mktg/Strtgy Officer | SELL | 4.2K | $61.17 | $256K |
| Jan 17, 23 | John WoockEVP, Chief Mktg/Strtgy Officer | SELL | 15.0K | $67.62 | $1.0M |
| Jan 13, 23 | Raymond W CohenChief Executive Officer | SELL | 22.1K | $66.27 | $1.5M |
| Jan 13, 23 | Alfred J Ford JrChief Commercial Officer | SELL | 17.1K | $67.18 | $1.1M |
| Dec 13, 22 | Esteban LopezDirector | SELL | 2.0K | $67.42 | $135K |
| Sep 13, 22 | Danny L. DearenSee Remarks | SELL | 656 | $75.60 | $50K |
| Sep 12, 22 | Karen NoblettChief Medical Officer | SELL | 32.5K | $78.16 | $2.5M |
| Sep 8, 22 | John WoockChief Marketing Officer | SELL | 3.8K | $75.01 | $285K |
| Sep 7, 22 | Karen NoblettChief Medical Officer | SELL | 10.5K | $71.53 | $748K |
| Aug 25, 22 | John WoockChief Marketing Officer | SELL | 7.0K | $73.34 | $507K |
| Aug 11, 22 | Danny L. DearenSee Remarks | SELL | 26.8K | $72.19 | $1.9M |
| Aug 10, 22 | Rinda SamaChief Operating Officer | SELL | 24.5K | $70.12 | $1.7M |
| Aug 10, 22 | John WoockChief Marketing Officer | SELL | 9.2K | $70.10 | $636K |
| Aug 8, 22 | Raymond W CohenChief Executive Officer | SELL | 18.1K | $72.09 | $1.3M |
| Aug 5, 22 | Rinda SamaChief Operating Officer | SELL | 12.7K | $71.40 | $899K |
| Jul 5, 22 | Jane E KiernanDirector | SELL | 5.3K | $60.00 | $315K |
| Apr 1, 22 | Jane E KiernanDirector | SELL | 1.8K | $62.71 | $110K |
| Mar 29, 22 | Raymond W CohenChief Executive Officer | SELL | 50.0K | $60.00 | $3.0M |
| Mar 29, 22 | Jane E KiernanDirector | SELL | 3.5K | $61.49 | $210K |
| Mar 18, 22 | Karen NoblettChief Medical Officer | SELL | 13.5K | $57.23 | $774K |
| Mar 14, 22 | Raymond W CohenChief Executive Officer | SELL | 17.8K | $54.80 | $926K |
| Mar 1, 22 | Danny L. DearenSee Remarks | SELL | 10.6K | $58.11 | $614K |
Over the past 12 months, insiders at Axonics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on AXNX, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at Axonics, Inc. filed open-market SEC Form 4 transactions on AXNX over the last 12 months.
InsiderTape plots every AXNX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Axonics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →